Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and
kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic …

A systematic review was undertaken to examine the evidence for B-type natriuretic peptides
(BNP and NT-proBNP) as independent predictors of mortality, morbidity, or combined …

Patients with heart failure (HF) are hospitalized over a million times annually in the United
States. Hospitalization marks a fundamental change in the natural history of HF, leading to …

Background Rehospitalization is a major cause for heart failure (HF)–related morbidity and
is associated with considerable loss of quality of life and costs. The rate of unplanned …

Accurate assessment of a patient's volume status, as well as whether they will respond to a
fluid challenge with an increase in cardiac output, is a critical task in the care of critically ill …

Brain natriuretic peptide (BNP) and its inactive N-terminal fragment, NT-proBNP, are serum
biomarkers with key roles in the management of heart failure (HF). An increase in the serum …

The study tests the hypothesis that in patients admitted with acutely decompensated heart
failure (ADHF), achievement of adequate body hydration status with intensive medical …

Cardio-Renal syndrome may occur as a result of either primarily renal or cardiac
dysfunction. This complex interaction requires a tailored approach to manage the underlying …

L'insufficienza cardiaca cronica è una complessa sindrome clinica caratterizzata spesso da
episodi ricorrenti di scompenso acuto. Tale condizione rappresenta uno dei maggiori …

Biomarkers have become an integral part of practicing medicine, especially in heart failure.
The natriuretic peptides are commonly used in the evaluation of heart failure, but their role …